Related Experiment Video
Updated: Nov 9, 2025

02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
589
Development of a shared decision-making tool in vitiligo: an international study
J Shourick1, M Ahmed2, J Seneschal3
1Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE), EA7379, Paris-Est University, UPEC, DHU VIC, Créteil, France.
The British Journal of Dermatology
|April 8, 2021
Summary
A new shared decision-making tool (SDMT) was developed for vitiligo patients. This validated tool aids joint medical decisions between physicians and patients, addressing treatment goals and disease management.
Area of Science:
- Dermatology
- Medical Informatics
- Patient-Centered Care
Background:
- Shared decision-making tools (SDMTs) enhance patient-physician collaboration but are scarce in dermatology.
- Vitiligo management lacks specialized visual tools for joint decision-making.
Purpose of the Study:
- To develop and validate a novel SDMT for vitiligo patients undergoing specialized consultations.
- To improve therapeutic decision-making processes in vitiligo care.
Main Methods:
- A prospective, cross-sectional study incorporating qualitative interviews and an e-Delphi method.
- Developed the SDMT based on 91 identified topics from patient-clinician discussions.
- Validated the tool's usefulness, satisfaction, and readability through cognitive interviews and a multidisciplinary working group.
Main Results:
- Identified 91 key topics in vitiligo therapeutic decision-making, categorized into general goals and treatment-specific issues.
- Created an eight-card SDMT covering repigmentation, depigmentation, coping, stabilization, and disease information.
- Cognitive interviews confirmed the SDMT's satisfaction, readability, and usefulness.
Conclusions:
- A novel, validated SDMT for nonsegmental vitiligo was successfully developed.
- The tool was translated and cross-culturally validated for a US patient population, ensuring generalizability.
- This SDMT facilitates shared decision-making in vitiligo management.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
2.9K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.9K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
482
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
482

